Press "Enter" to skip to content

BeiGene drug fails main goal in late-stage study against AbbVie-J&J rival Imbruvica

The trial tested the drugs in patients with Waldenstrom’s Macroglobulinemia, a type of non-Hodgkin lymphoma.

Original source: https://health.economictimes.indiatimes.com/news/pharma/beigene-drug-fails-main-goal-in-late-stage-study-against-abbvie-jj-rival-imbruvica/72761225?utm_source=RSS&utm_medium=ETRSS

Also Read:   French pharma group Ipsen closes in on its next drug deals